Rapid Infusion Daratumumab Is Safe in Patients with AL Amyloidosis

被引：1
|
作者：
Rosko, Nathaniel [1 ]
Mo, Hanjie [1 ]
Rudoni, Joslyn [1 ]
Siebenaller, Caitlin [1 ]
Lee, Sarah S. [2 ]
Chakraborty, Rajshekar [2 ]
Faiman, Beth M. [2 ]
Khouri, Jack [2 ]
Garcia, Alex V. Mejia [2 ]
Samaras, Christy J. [2 ]
Anwer, Faiz [2 ]
Valent, Jason [2 ]
机构：
[1] Cleveland Clin, Dept Pharm, Cleveland, OH 44106 USA
[2] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-124775
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1838
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Daratumumab Is Safe and Highly Effective in AL Amyloidosis
    Khouri, Jack
    Bicky, Thapa
    Reu, Frederic J.
    Samaras, Christy J.
    Liu, Hien D.
    Karam, Mary Ann
    Reed, Janice
    Faiman, Beth M.
    Valent, Jason
    [J]. BLOOD, 2017, 130
  • [2] Daratumumab proves safe and highly effective in AL amyloidosis
    Khouri, Jack
    Kin, Andrew
    Thapa, Bicky
    Reu, Frederic J.
    Bumma, Naresh
    Samaras, Christy J.
    Liu, Hien D.
    Karam, Mary A.
    Reed, Janice
    Mathur, Saveta
    Faiman, Beth M.
    Devries, Georgia
    Zonder, Jeffrey
    Valent, Jason
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (02) : 342 - 344
  • [3] Rapid Infusion Daratumumab Is Safe and Well Tolerated in Clinical Practice
    Hamadeh, Issam S.
    Arnall, Justin
    Kachur, Ekaterina
    Martin, Allison
    Jagosky, Megan Helena
    Friend, Reed
    Atrash, Shebli
    Bhutani, Manisha
    Voorhees, Peter M.
    Usmani, Saad Z.
    [J]. BLOOD, 2018, 132
  • [4] Daratumumab for AL amyloidosis
    Allison S.
    [J]. Nature Reviews Nephrology, 2021, 17 (9) : 572 - 572
  • [5] IS DARATUMUMAB ELIMINATED IN THE URINE OF PATIENTS WITH AL AMYLOIDOSIS?
    Gil Alos, D.
    Cuevas Gomez, D.
    Colmenares Gil, R.
    Gil Manso, R.
    Iniguez Garcia, R.
    Zamanillo Herrero, I
    Poza Santaella, M.
    Puerta Fonolla, P.
    Sanchez Pina, J. M.
    Martinez Lopez, J.
    [J]. HAEMATOLOGICA, 2021, 106 (10) : 150 - 150
  • [6] Daratumumab yields rapid and deep hematologic responses in patients with heavily pretreated AL amyloidosis
    Kaufman, Gregory P.
    Schrier, Stanley L.
    Lafayette, Richard A.
    Arai, Sally
    Witteles, Ronald M.
    Liedtke, Michaela
    [J]. BLOOD, 2017, 130 (07) : 900 - 902
  • [7] ACCELERATED INFUSION OF DARATUMUMAB IS SAFE IN MULTIPLE MYELOMA PATIENTS
    Jak, M.
    Oostvogels, R.
    Minnema, M. C.
    [J]. HAEMATOLOGICA, 2018, 103 : 20 - 20
  • [8] Daratumumab for the treatment of AL amyloidosis
    Sidiqi, M. Hasib
    Gertz, Morie A.
    [J]. LEUKEMIA & LYMPHOMA, 2019, 60 (02) : 295 - 301
  • [9] Rapid Hematologic and Organ Responses with Daratumumab, Bortezomib and Dexamethasone in Patients with Relapsed/Refractory AL Amyloidosis
    Lee, Sarah S.
    Rosko, Nathaniel
    Patel, Bhumika J.
    Waldron, Madeline
    Tomer, Jackie
    Goldman, Roman
    Karam, Mary Ann
    Reed, Janice
    Faiman, Beth M.
    Hamilton, Kimberly
    Mathur, Saveta
    Samaras, Christy J.
    Valent, Jason
    [J]. BLOOD, 2018, 132
  • [10] TREATMENT WITH DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA ASSOCIATED AL AMYLOIDOSIS
    Fazio, F.
    Basset, M.
    Milani, P.
    Foli, A.
    Nuvolone, M.
    Foa, R.
    Petrucci, M. T.
    Merlini, G.
    Palladini, G.
    [J]. HAEMATOLOGICA, 2019, 104 : 11 - 11
12345